Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Long-acting PrEP: new opportunities with some drawbacks.Published in
Lancet HIV 2023;online ahead of printPMID
36642088ae974a485f413a2113503eed53cd6c53
10.1016/S2352-3018(22)00397-6
Scopus Count
Collections
Related articles
- Potential effectiveness of long-acting injectable pre-exposure prophylaxis for HIV prevention in men who have sex with men: a modelling study.
- Authors: Marshall BDL, Goedel WC, King MRF, Singleton A, Durham DP, Chan PA, Townsend JP, Galvani AP
- Issue date: 2018 Sep
- Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.
- Authors: van Vliet MM, Hendrickson C, Nichols BE, Boucher CA, Peters RP, van de Vijver DA
- Issue date: 2019 Dec
- Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection.
- Authors: Walensky RP, Jacobsen MM, Bekker LG, Parker RA, Wood R, Resch SC, Horstman NK, Freedberg KA, Paltiel AD
- Issue date: 2016 May 15
- Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
- Authors: Bershteyn A, Sharma M, Akullian AN, Peebles K, Sarkar S, Braithwaite RS, Mudimu E
- Issue date: 2020 Jun
- PrEParing for long-acting injectable PrEP in the South: perspectives from healthcare providers in Georgia.
- Authors: Xavier Hall CD, Smith JC, Driggers RA, Stoller B, Khan Z, Li J, Ignatius EH, Siegler AJ
- Issue date: 2021 Jun